glp 2 vs glp 1 GLP-1 Medications for Weight Loss: Semaglutide Tirzepatide vs Retat – Revolution Health & Wellness Effects of glucagon-like peptide 2
Description
Pharma companies like Roche, Amgen, Pfizer, and AstraZeneca are among the contenders expected to release additional obesity drugs in the next three to four years
Diabetologia (2006) 49:70612
19 In the study, the researchers used a large electronic health record database to conduct a nationwide retrospective cohort study to assess the association of semaglutide with the incidence and recurrence of suicidal ideation compared with non-GLP1R agonist anti-obesity medications in individuals with overweight or obesity
Mathur, B
